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The modular multifunctional protein large T antigen (T-ag)
from simian virus 40 orchestrates many of the events needed
for replication of the viral double-stranded DNA genome.
This protein assembles into single and double hexamers on
speciﬁc DNA sequences located at the origin of replication.
This complicated process begins when the origin-binding
domain of large T antigen (T-ag ODB) binds the GAGGC
sequences in the central region (site II) of the viral origin of
replication. While many of the functions of puriﬁed T-ag
OBD can be studied in isolation, it is primarily monomeric in
solution and cannot assemble into hexamers. To overcome this
limitation, the possibility of engineering intermolecular
disulﬁde bonds in the origin-binding domain which could
oligomerize in solution was investigated. A recent crystal
structure of the wild-type T-ag OBD showed that this domain
forms a left-handed spiral in the crystal with six subunits per
turn. Therefore, we analyzed the protein interface of this
structure and identiﬁed two residues that could potentially
support an intermolecular disulﬁde bond if changed to
cysteines. SDS–PAGE analysis established that the mutant
T-ag OBD formed higher oligomeric products in a redox-
dependent manner. In addition, the 1.7 A ˚ resolution crystal
structure of the engineered disulﬁde-linked T-ag OBD is
reported, which establishes that oligomerization took place in
the expected manner.
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1. Introduction
Simian virus 40 (SV40) is a member of the polyoma virus
family and has long served as a model system for the study of
eukaryotic DNA replication (for reviews, see Bullock, 1997;
Fanning & Knippers, 1992; Simmons, 2000). In this virus,
replication depends upon a single viral protein, large Tantigen
(T-ag), with the other necessary factors being provided by the
cellular host.
The site at which DNA replication initiates, termed the
origin of replication, contains three important regions: a
central region with four pentameric GAGGC sequences
arranged as two pairs of inverted repeats (termed site II) and
two ﬂanking regions termed the AT-rich region and the EP
region (Deb et al., 1986). For SV40, this minimal 64-base-pair
origin sequence, termed the core origin, is sufﬁcient to support
T-ag assembly and initiation of viral DNA replication
(reviewed in Borowiec et al., 1990). Electron-microscopy
studies have shown that upon binding the core origin T-ag
molecules assemble into head-to-head double hexamers
(Mastrangelo et al., 1989; Valle et al., 2000).
T-ag contains three structurally and functionally indepen-
dent domains: an N-terminal J domain followed by the origin-
binding domain (OBD) and the helicase domain. The Jdomain, while necessary for transformation (reviewed in
Pipas, 2009), is not essential for replication in vitro (Campbell
et al., 1997). The T-ag OBD has multiple functions (Wun-Kim
et al., 1993); it binds the GAGGC sequences in the origin of
replication in a sequence-speciﬁc manner. The T-ag OBD can
also bind nonspeciﬁc dsDNA and ssDNA (see, for example,
Fradet-Turcotte et al., 2007; Reese et al., 2006; Simmons,
Loeber et al., 1990; Simmons, Wun-Kim et al., 1990).
The helicase domain belongs to helicase superfamily 3
(SF3) and is a member of the AAA+ (ATPases associated
with diverse cellular activities) family (for a review, see
Erzberger & Berger,2006). The T-ag helicase forms hexameric
ring structures that work as molecular motors to unwind DNA
using ATP hydrolysis (Li et al., 2003).
Crystal and NMR structures are available for each of the
individual domains in a variety of states, although no high-
resolution structure yet exists for the full-length protein. For
example, crystal structures of the T-ag OBD on DNA con-
taining the four GAGGC sequences (Bochkareva et al., 2006),
as well as on a pair of GAGGC sequences (Meinke et al.,
2007), have been solved. Crystal structures also exist of T-ag
OBD interacting with dsDNA in a nonsequence-speciﬁc
manner (Bochkareva et al., 2006; Meinke et al., 2011) and a
recent crystal structure shows how T-ag OBD interacts with
the ssDNA portion of a forked-DNA substrate (Meinke et al.,
2011).
Owing to the modular nature of T-ag, many of its functions
may be studied by examining the isolated domains. For
example, the helicase domain has ATPase activity similar to
that of the full-length protein (Gai et al., 2004). In the case of
the T-ag OBD, many of its DNA-binding properties have been
measured using the puriﬁed isolated domain (see, for example,
Fradet-Turcotte et al., 2007; Joo et al., 1997; Reese et al., 2006;
Titolo et al., 2003). However, unlike the helicase domain,
which oligomerizes readily into hexamers in the presence of
ADP, ATP or an analog, the isolated OBD remains mono-
meric in solution even at concentrations of >1 mM (Luo et al.,
1996).
Our structure of the T-ag OBD (PDB entry 2fuf) crystal-
lized in a hexagonal space group in which the protein formed
a helical ﬁlament in the crystal with six monomers per turn
(Meinke et al., 2006). We proposed that a single turn of the
helical ﬁlament (which we term the open-ring or ‘lock-washer’
structure) may be biologically relevant. Furthermore, we
proposed that it would form after recognition of the GAGGC
sequences by the T-ag OBD (Meinke et al., 2007) and subse-
quent assembly events by the helicase domain (Kumar et al.,
2007). This ‘open-ring’ structure of the T-ag OBD has a
positively charged central channel that is large enough to
accommodate dsDNA or even two opposing strands of
ssDNA. The ‘gap’ in the open ring may also provide a path
through which ssDNA can pass. Furthermore, this structure
provided the ﬁrst high-resolution view of the residues in T-ag
OBD that are involved in the protein–protein interactions
required for hexamer formation. Of note, the overall dimen-
sions of the spiral hexamer T-ag OBD structure ﬁt those seen
in cryo-EM studies of larger constructs of T-ag assembled on
origin-containing DNA substrates (Cuesta et al., 2010; Valle et
al., 2000, 2006).
Because the full-length T-ag functions as a hexamer, we
wished to engineer a ring form of the isolated T-ag OBD.
Using structure-based design, we identiﬁed a pair of residues
at the protein–protein interface that were predicted to support
disulﬁde-bond formation upon mutation to cysteines. We
generated this mutant form of T-ag OBD and established that
it formed the predicted higher order complexes in a redox-
dependent manner. To validate the hypothesis that an inter-
molecular disulﬁde bond formed at the mutated positions
within the spiral structure, we solved the crystal structure of
this mutant T-ag OBD containing a pair of engineered
cysteines. These data support the hypothesis that the disulﬁde-
linked T-ag OBDs form a spiral in solution.
2. Materials and methods
2.1. Structure-based design of a disulfide bond
The program SSBOND (Hazes & Dijkstra, 1988) analyzes
protein structures and identiﬁes pairs of residues that can
support disulﬁde-bond formation if mutated to cysteines. We
used SSBOND to analyze the protein–protein interface of the
SV40 T-ag OBD open-ring hexamer crystal structure (PDB
entry 2fuf). The program identiﬁed only one possible pair of
residues (Phe151 and Asp256) as having the potential to form
a disulﬁde bond. In addition, analysis of the wild-type (wt)
T-ag OBD structure revealed that only one of the three
existing cysteines in the wt T-ag OBD structure is solvent-
accessible (Cys216) and thus a potential problem for these
analyses.
2.2. Vector construction
2.2.1. Generation of mutant T-ag OBD. The pGEX TBD
vector expresses wild-type SV40 T-ag OBD131–260 (amino acids
131–260) as a thrombin-cleavable GST-fusion protein and
has been described elsewhere (Joo et al., 1997). Alanine or
cysteine substitutions were introduced at targeted positions
using the QuikChange site-directed mutagenesis kit (Strata-
gene), plasmid pGEX TBD and appropriate DNA oligo-
nucleotides (shown in Table 1). The thermocycling conditions
consisted of an initial denaturation step at 368 K for 60 s
followed by 12 cycles of denaturation at 368 K for 50 s,
annealing at 328 K for 60 s, polymerase extension at 341 K for
11 min and a ﬁnal extension of 5 min. The DNA sequences of
all mutant plasmids described in this report were conﬁrmed by
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Table 1
Oligonucleotides for QuikChange mutagenesis.
T-ag mutation Oligonucleotides for QuikChange mutagenesis
(their complements are not shown)
C216A 50-CTGCTATTAATAACTATGCTCAAAAATTGGC-
TACCTTTAGCTTTTTAATTTGTAAAGGGG-30
F151C 50-AGTTTTTTGAGTCATGCTGTGTGTAGTAATA-
GAACTCTTGCTTGC-30
D256C 50-CCAGGTGGGTTAAAGGAGCATTGTTTTAATCCA-
GAAGAAGCAGA-30the dideoxy sequencing method at the Tufts Core Facility. The
following four T-ag OBD mutants were produced: (i) T-ag
OBDC216A,( i i )T - a gO B D C216A, F151C, (iii) T-ag OBDC216A, D256C
and (iv) T-ag OBDC216A, F151C, D256C.
2.2.2. Generation of mutant full-length T-ag. Plasmid
pCMVneoT-ag (Campbell et al., 1997) was used for expression
of T-ag. Mutant forms of full-length T-ag were prepared using
the QuikChange kit (Stratagene) with pCMVneoT-ag as the
substrate and the primers listed in Table 1. The thermocycling
conditions were identical to those listed above.
2.3. Protein expression and purification
The T-ag OBD mutants were expressed and puriﬁed in a
similar manner as the wild type (Meinke et al., 2006). Brieﬂy,
upon induction with IPTG (isopropyl -d-1-thiogalacto-
pyranoside), the GST fusion was overexpressed in Escherichia
coli strain BL21 (DE3). The cells were lysed and spun down
and the GST fusion was puriﬁed on a glutathione Sepharose
4B column. This was followed by digestion with thrombin and
two further chromatographic steps: cation exchange (Source S
resin) followed by gel ﬁltration. The T-ag OBD mutants were
puriﬁed as described previously, with the exception that the
Sephacryl S-100 column was replaced by a Superdex 75 10/300
GL column. Upon puriﬁcation to apparent homogeneity, the
T-ag OBD mutants were stored in storage buffer (20 mM Tris–
HCl pH 8.0, 50 mM NaCl, 0.1% -mercaptoethanol and 10%
glycerol) at 193 K until ready for use.
2.4. Cysteine–cysteine cross-linking catalyzed by
Cu(1,10-phenanthroline)2SO4 (CuP)
The phenanthroline copper complex has been shown to
catalytically oxidize sulfhydryl groups (Kobashi, 1968). The
cross-linking protocol described here is adapted from Jiang &
Fillingame (1998). The stock protein (wt or mutant T-ag OBD)
was diluted to 1 mg ml
 1 in 1  reaction buffer (10 mM Tris
pH 7.5, 100 mM NaCl, 5% glycerol). A fresh 10  Cu(1,10-
phenanthroline)2SO4 (CuP) solution was prepared by making
a1 5m M CuSO4,5 0m M 1,10-phenanthroline solution.
Each 50 ml cross-linking reaction contained 10 mg protein
(unless otherwise indicated) in 1  reaction buffer to which a
1/10 volume of 10  CuP was added. This mixture was allowed
to incubate for 60 min at room temperature.
The cross-linking reaction was terminated by the addition of
EDTA to a ﬁnal concentration of 50 mM and the addition of
N-ethylmaleimide to a ﬁnal concentration of 2 mM. After
15 min at room temperature, a 1/6 volume of 6  SDS sample
buffer (350 mM Tris–HCl pH 6.8, 10% SDS, 30% glycerol,
0.12 mg ml
 1 bromophenol) was added to the reaction. This
mixture was allowed to incubate at room temperature for 1 h.
If the cross-link was to be reduced, DTTwas then added to a
ﬁnal concentration of 25 mM. The products were then
electrophoresed on 12–15% SDS gels and analyzed via
Coomassie staining.
2.5. Luciferase transient DNA-replication assay
A quantitative assay to study the replication of polyoma
and papilloma viruses has recently been described (Fradet-
Turcotte et al., 2010). This assay measures the ability of full-
length or mutants of T-ag to replicate an origin-containing
plasmid that also has a luciferase reporter gene. We generated
T-ag containing mutations at residues in the spiral interface
of the T-ag OBD involved in disulﬁde-bond formation and
subjected them to this assay. The following three mutants were
made in the parental pCMVneoT-ag expression vector: (i)
F151C, (ii) D256C and (iii) F151C, D256C.
To perform the assay, 5   10
4 C33A cells were transfected
with three plasmids encoding T-ag, the minimal origin of DNA
replication together with a ﬁreﬂy luciferase reporter gene and
Renilla luciferase. Replication of the origin-containing plasmid
was quantiﬁed 72 h post-transfection by measuring the levels
of ﬁreﬂy and Renilla luciferase activities using a Dual-Glo
Luciferase assay system (Promega). Each T-ag mutant was
analyzed in duplicate in two separate experiments. Error bars
represent the standard deviations.
2.6. Western blotting assay
Western blotting was performed via standard methods;
extracts were prepared 24 h post-transfection. T-ag proteins
were detected using a mouse monoclonal antibody recog-
nizing an epitope located within the N-terminal 82 amino acids
of the protein (Sc-148; Santa Cruz). Tubulin was used as a
loading control.
2.7. Crystallization of the SV40 T-ag OBD triple mutant
(F151C, C216A, D256C)
Crystallization of the T-ag OBDF151C, C216A, D256C triple
mutant (3XM) was performed by screening around conditions
that previously yielded diffraction-quality crystals. Initial
microcrystals were grown under conditions similar to the
published conditions for the wt T-ag OBD hexagonal crystal
form (Meinke et al., 2006), although growing single crystals of
the triple mutant proved difﬁcult. It was previously observed
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Table 2
Crystallographic data and reﬁnement statistics for T-ag OBDF151C, C216A, D256C.
Values in parentheses are for the highest resolution shell.
PDB code 3qn2
Beamline NSLS X29
Wavelength (A ˚ ) 1.075
Space group P65
Unit-cell parameters (A ˚ ,  ) a = b = 83.933, c = 35.872,
 =  = 90.000,  = 120.000
Resolution (A ˚ ) 50–1.66 (1.72–1.66)
Rmerge (%) 9.2 (50.0)
hI/(I)i 44.8 (7.1)
Completeness (%) 99.9 (99.5)
Multiplicity 21.6 (20.2)
Reﬁnement
Resolution (A ˚ ) 50–1.66
No. of reﬂections 17264
Rwork/Rfree 16.96/19.12
R.m.s. deviations
Bond lengths (A ˚ ) 0.005
Bond angles ( ) 0.920that wt T-ag OBD hexagonal crystals were also obtained in the
presence of excess single-stranded DNA (ssDNA; unpub-
lished data). Therefore, ssDNA (12-mer of poly-dT resus-
pended in 10 mM Tris pH 7.5, 50 mM NaCl; Integrated DNA
Technologies) was added in a molar ratio of 2:1 to the 3XM
protein to help grow larger crystals. In general, crystals of the
triple mutant grew as clusters of small crystals which had to
be cut using a microtool to obtain a single crystal. The best
crystals were obtained by the vapour-diffusion method at
room temperature in a 24-well Linbro tray. The 1 ml well
solution consisted of 1.6 M sodium citrate pH 6.5. The crystals
were grown from drops made up of 3 ml protein solution
(6.4 mg ml
 1 3XM and a twofold molar excess of 12-mer poly-
dT in protein storage buffer) and 4 ml well solution.
2.8. X-ray data collection, structure solution and refinement
The crystals were transferred to a cryogenic solution using
a nylon microloop (Hampton Research) and then frozen in
liquid nitrogen. The cryogenic solution used for the T-ag OBD
triple mutant consisted of 1.36 M sodium citrate pH 6.5 and
15% ethylene glycol. X-ray data were collected at 100 K using
an ADSC Quantum-315r nine-quadrant charge-coupled
device (CCD) detector on National Synchrotron Light Source
(NSLS) beamline X-29 (Brookhaven National Laboratory,
New York, USA). The X-ray data were processed with the
HKL-2000 suite (Otwinowski & Minor, 1997). The unit-cell
parameters and diffraction statistics are shown in Table 2. The
structure of the triple mutant was solved by molecular
replacement using apo T-ag OBD coordinates as a search
model (PDB entry 2fuf) and the program Phaser (McCoy et
al., 2005). The structure was reﬁned using REFMAC
(Murshudov et al., 2011) within the CCP4 suite of programs
(Winn et al., 2011) and PHENIX (Adams et al., 2010). Four
TLS (translation/libration/screw) groups were identiﬁed
(Painter & Merritt, 2006) and were included in the ﬁnal steps
of reﬁnement. The resulting maps and models were visualized
and improved with the molecular-graphics programs Coot
(Emsley et al., 2010) and PyMOL (Schrodinger LLC).
PDBSUM was used to analyze the protein–protein interface
(Laskowski, 2009). All molecular-
graphics ﬁgures in this paper were
produced with PyMOL.
3. Results and discussion
3.1. Structural analysis of the spiral
hexamer of wt SV40 T-ag OBD
As previously mentioned, the T-ag
OBDs interact with each other when the
full-length T-ag forms single or double
hexamers, whereas in solution the
puriﬁed isolated OBD is primarily
monomeric.
We have shown that wt T-ag OBD
forms a ﬁlament in the crystal (Meinke
et al., 2006). This crystal structure of wt
SV40 T-ag OBD (PDB entry 2fuf) has
one monomer in the asymmetric unit
and six monomers per turn (Figs. 1a and
1b). The monomers pack in a head-
to-tail arrangement. We analyzed the
protein–protein interface of this high-
resolution crystallographic hexamer
using SSBOND (Hazes & Dijkstra,
1988). SSBOND predicts which pairs of
residues, if mutated to cysteines, could
reasonably form disulﬁde bonds. When
the wt T-ag OBD structure was analyzed
via the program SSBOND, we identiﬁed
only one pair as candidates for muta-
tion: Phe151 and Asp256. The positions
of these residues are shown in Figs. 1(a)
and 1(b) and a close-up view is shown
in Fig. 1(c). A theoretical model of the
disulﬁde linkage is shown in Fig. 1(d).
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Figure 1
Crystal structure of the spiral hexamer structure of wt SV40 T-ag OBD shown as a ribbon diagram.
(a) This ‘top’view islooking down thesixfold axis.Aclose-up view ofthearea bounded by theblack
box is shown in (c). (b) This ‘side’ view is rotated  90  relative to the view in (a) and clearly shows
the ‘gap’. Alternating monomers of T-ag OBD are colored cyan and green, respectively. The
residues Phe151, Cys216 and Asp256 are shown as orange, yellow and magenta spheres,
respectively.(c)A close-up view of theinterface showing Phe151 (orange) and Asp256 (magenta) as
sticks.Note that there are no side chains modelled for the Asp256 residue. (d) A molecular model of
the disulﬁde bridge that could form between F151C and D256C. The S atoms are colored yellow.Further visual inspection of the structure of T-ag OBD
revealed one surface cysteine (Cys216; shown in Figs. 1a and
1b). Indeed, the crystal structure of a Cys216–Cys216 disul-
ﬁde-linked T-ag OBD dimer has been reported (PDB entry
2if9; Meinke et al., 2007). Therefore, to eliminate disulﬁde
formation with Cys216, we also mutated Cys216 to alanine
(Cys216Ala).
3.2. Cys216Ala T-ag OBD is monomeric
The wt T-ag OBD is monomeric under reducing conditions
and remains as a monomer even at high concentrations (Luo
et al., 1996). However, as shown in Fig. 2, under oxidizing
conditions some of the wt T-ag OBD forms dimers, whereas
the Cys216Ala mutant does not. This conﬁrms the hypothesis
that under oxidizing conditions the surface Cys216 is respon-
sible for the formation of disulﬁde-linked dimers of wt T-ag
OBD.
3.3. Double mutants form redox-dependent dimers; the triple
mutant forms redox-dependent higher order oligomers
Using the vector encoding the Cys216Ala mutant (pGEX
T-ag OBDC216A), we generated two additional vectors
encoding the double mutants Cys216Ala, Phe151Cys and
Cys216Ala, Asp256Cys. The mutant T-ag OBDs encoded by
these vectors were puriﬁed and analyzed; these double
mutants primarily formed dimers under oxidizing conditions,
as shown in Fig. 3. Finally, using a vector encoding a double
mutant of T-ag OBD (pGEX T-ag OBDC216A, F151C), we
generated a vector encoding the triple-mutant form T-ag
OBDF151C, C216A, D256C (termed 3XM). Fig. 4 shows that the
triple mutant behaves like the wild type under reducing
conditions (i.e. it is a monomer). However, under oxidizing
conditions 3XM forms higher order complexes (dimers,
trimers etc.) as analyzed by SDS–PAGE (Fig. 4). These higher
order complexes are observed by overnight dialysis in the
absence of reducing agent (data not shown), as well as by
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Figure 2
T-ag OBD Cys216A mutant is monomeric in solution. Results of Cu(1,10-
phenanthroline)2SO4 (CuP) catalyzed oxidation experiments electro-
phoresed on an SDS–polyacrylamide gel and stained with Coomassie
Brilliant Blue. Lane 4 contains molecular-weight markers (250, 150, 100,
75, 50, 37, 25, 20, 15 and 10 kDa). Lanes 1–3 contain wt T-ag OBD and
lanes 5–7 contain the C216A mutant protein. Lanes 2 and 6 show the
results of CuP oxidation and lanes 3 and 7 show the results of oxidation
with CuP followed by treatment with the reducing agent DTT. These data
show that under oxidizing conditions the wt OBD forms dimers, whereas
the C216A mutant remains monomeric.
Figure 3
T-ag OBD double mutants primarily form dimers. Results of Cu(1,10-
phenanthroline)2SO4 (CuP) catalyzed oxidation experiments electro-
phoresed on an SDS-polyacrylamide gel and stained with Coomassie
Brilliant Blue. Lane 3 contains molecular-weight markers (250, 150, 100,
75, 50, 37, 25, 20, 15 and 10 kDa). Lanes 1–2 show C216A, F151C mutant
OBD and lanes 4–5 show C216A, D256C mutant protein. Lanes 1 and 4
show the results of CuP oxidation and lanes 2 and 5 show the results of
overnight dialysis in reaction buffer (no reducing agent). These data show
that under oxidizing conditions the double mutants form dimers, unlike
the single C216A mutant.
Figure 4
T-ag OBD triple mutants form ladders. Results of Cu(1,10-phenanthro-
line)2SO4 (CuP) catalyzed oxidation experiments electrophoresed on an
SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue. Lane
3 contains molecular-weight markers (250, 150, 100, 75, 50, 37, 25, 20, 15
and 10 kDa). Lanes 4–8 contain varying amounts of the triple mutant
(3XM): 1x,2 x or 4x, where x = 1 mg ml
 1. Lane 1 contains the reduced
3XM protein and lanes 2 and 4 show the 3XM protein after overnight
dialysis in reaction buffer in the absence of reducing agent. Lane 5 shows
the results of CuP oxidation. Lane 6 shows the results of oxidation
followed by the addition of DTT. Lanes 7 and 8 are similar to lane 5 but
with increasing concentrations of 3XM. The arrows indicate higher order
species (e.g. monomers, dimers, trimers etc.). These data show that under
oxidizing conditions (either by dialysis or treatment with CuP), the triple
mutant forms ladders (to a much greater extent than the wild type) that
can be removed by treatment with the reducing agent DTT.using the copper-catalyzed cross-linking protocol described in
x2. These higher order complexes disappear on the addition of
a reducing agent such as DTT (lane 6, Fig. 4). Only the triple
mutant containing both cysteines had a strong propensity to
form higher order complexes.
3.4. Testing the ability of full-length T-ag molecules with
cysteine mutations in the OBD to catalyze DNA replication
The cysteine mutations were introduced into vectors
encoding full-length T-ag (x2) and their ability to support
DNA replication was analyzed in vivo in transfected cells
(Fig. 5). Residue Phe151 has previously been shown to be
important for a variety of T-ag’s functions (see, for example,
Meinke et al., 2011), so it is not surprising that the F151C
mutant is severely impaired for replication. In contrast, the
D256C mutation has no effect on replication; this residue is
located in the ﬂexible hinge region between the OBD and
the helicase domain, which may explain why this mutation is
tolerated. Finally, the double mutant (F151C, D256C) was also
inactive, presumably owing to the F151C mutation.
3.5. Crystal structure of the T-ag OBD triple mutant (3XM)
To verify that the desired intermolecular disulﬁde bond
formed between Phe151Cys and Asp256Cys, we crystallized
the triple mutant and subjected the crystals to X-ray analysis.
The triple mutant crystallized under similar conditions to
wt T-ag OBD. The crystals were much smaller and had to be
dissected from a larger cluster. As previously noted, single-
stranded DNA (ssDNA) was added to improve the crystals.
No ordered ssDNA was visible in the electron density and
there is no DNA in the model. The triple mutant crystallized in
the same space group (P65) and has almost identical unit-cell
parameters as the wt T-ag OBD.There is one 3XM moleculein
the asymmetric unit. Data were collected to 1.66 A ˚ resolution
and reﬁned to a ﬁnal R factor of 17.0% and Rfree of 19.1%. The
ﬁnal model contains amino acids 131–252 and 254–257, 127
water molecules and one citrate molecule. Residues lacking
side-chain electron density are modelled as ‘stubs’ (i.e. as
alanine). One turn of the 3XM spiral is shown in Fig. 6(a).
The triple-mutant ODB has two regions of high ﬂexibility
and these are also the regions of the weakest electron density,
indicating conformational ﬂexibility. One region of high ﬂex-
ibility spans residues 213–218 (which includes the surface
Cys216Ala mutation). Interestingly, this region (termed the
B3 motif or loop) has been shown by mutagenesis to be
important for the assembly of double hexamers in the context
of full-length T-ag (Weisshart et al., 1999). As this region was
also difﬁcult to trace in the wt T-ag OBD structure, we
proposed previously that the inherent ﬂexibility of this region
may play a role in double-hexamer formation of full-length
T-ag (Meinke et al., 2006). The other region of weak electron
density occurs in the C-terminal portion, which includes the
D256C mutation. A view of the electron density highlighting
the ‘spiral’ interface which includes the F151C, D256C disul-
ﬁde bridge is shown in Fig. 6(b). The C-terminal portion of
T-ag OBD has been shown to adopt alternate conformations
in different structures of T-ag OBD (PDB entries 1tbd, 2fuf,
2ntc, 2if9, 2ipr, 2itj, 2itl and 2nl8; Meinke et al., 2006, 2007; Luo
et al., 1996; Bochkareva et al., 2006), indicating that it is also a
region of high ﬂexibility. However, it is clear that there is some
structural rearrangement of the C-terminal region in this
structure relative to the wt structure, starting at amino acid
250. Indeed, the residues in this region are difﬁcult to trace as
a result of conformational ﬂexibility. Nonetheless, the electron
density for the disulﬁde bond connecting the protomers is
clear.
Phe151 made extensive intermolecular contacts in the wt
structure, so it is not surprising that some rearrangements
occur when the large hydrophobic side chain is replaced by a
smaller group. As a consequence, the wt structure buries
larger surface areas ( 570 and 670 A ˚ 2, respectively) than the
3XM structure ( 480 and 570 A ˚ 2, respectively) as calculated
using PDBSUM (Laskowski, 2009). Despite the indicated
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Figure 5
DNA-replication activity of T-ag mutant proteins. (a) Transient DNA-
replication activities of the indicated wt or mutant T-ag proteins in C33A
cells. DNA-replication activities were measured by determining the ratio
of ﬁreﬂy (Fluc-ori plasmid) to Renilla (Rluc control plasmid) luciferase
activities as described in x2. Replication activities are reported as a
percentage of the Fluc:Rluc ratio obtained with the largest amount of wt
T-ag expression vector (12 ng). Cells transfected with vector only (No
T-ag) were used as a negative control. (b) Expression of T-ag proteins.
Western blot analysis of total protein extracts prepared from transfected
C33A cells expressing the wt or the indicated T-ag mutant proteins. Each
protein was tested using a gradient of expression vector (0, 1.25, 2.5,
5.0, 10 and 12.5 ng). 100% replication was deﬁned as the amount of
replication observed using 12.5 ng wt T-ag.changes, the backbones of the two structures are virtually
identical. Superposition of the two structures yields a root-
mean-square deviation (r.m.s.d.) of 0.79 A ˚ over 123 C
 atoms.
Examination of the 3XM protein–protein interface shows that
some contacts are absent in the mutant protein interface that
were present in the wt structure. For example, a salt bridge
between Lys214 and Glu177 that was observed in the wt
structure is absent from the mutant structure. The structural
rearrangements seen in our mutant spiral structure do not
occur in the DNA-binding residues, which are primarily resi-
dues 147–155 and 203–207 (Simmons, Loeber et al., 1990).
Indeed, the r.m.s.d. between the wt and mutant structures
is 0.139 A ˚ (111 C
 atoms, residues 131–212 and 220–248).
Therefore, in terms of DNA binding, our mutant spiral
structure should behave similarly to the wt protein in its
presumptively natural spiral form. Finally, although the triple
mutant has reorganized a portion of the protein–protein
interface, the disulﬁde cross-link, together with the other
protein–protein interactions, are sufﬁcient for formation of
the crystallographic hexamer.
The crystal structure reported here demonstrates that the
engineered cysteines in the T-ag OBD can form inter-
molecular disulﬁde bonds in a spiral hexamer. Furthermore,
this mutant allows us to form higher order oligomers of T-ag
OBD in solution, something that was not previously possible.
In addition to the crystallographic spiral observed for the
SV40 T-ag OBD (Meinke et al., 2006), spiral protein assem-
blies have been reported for other proteins involved in nucleic
acid remodelling. Examples include the bacterial replication
initiator DnaA (Erzberger et al., 2006) and the eukaryotic
ORC initiator from Drosophila melanogaster (Clarey et al.,
2006; reviewed by O’Donnell & Jeruzalmi, 2006). Protein
assemblies known to form both ﬂat rings and helical ﬁlaments
include bacterial RecA (Yu & Egelman, 1997), archaeal RadA
(Yang et al., 2001) and Methanothermobacter thermauto-
trophicus MCM (Chen et al., 2005). However, the ability to
form a helical versus ﬂat ring assembly for some systems
appears to be a function of the protein-fragment length, as for
the T7 Gp4 bacteriophage helicase domain; i.e. shorter frag-
ments result in helical ﬁlaments (Sawaya et al., 1999) and
longer fragments in ﬂat-ring structures (Singleton et al., 2000;
Toth et al., 2003).
3.6. Conclusions
We now have a tool to probe the importance of oligomer-
ization of T-ag OBD in a variety of biophysical studies by
comparing the monomeric form of wt T-ag OBD with the
higher order oligomer form of the disulﬁde-linked mutant. In
addition, this represents a new reagent for studies of the
oligomeric requirement for binding of cellular DNA replica-
tion factors to the T-ag OBD.
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